Ladenburg Thalmann Financial Services’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $17K | Buy |
113,150
+107,000
| +1,740% | +$16.1K | ﹤0.01% | 4240 |
|
|
2019
Q3 | $1K | Hold |
6,150
| – | – | ﹤0.01% | 5228 |
|
|
2019
Q2 | $1K | Sell |
6,150
-447
| -7% | -$73 | ﹤0.01% | 5226 |
|
|
2019
Q1 | $1K | Buy |
6,597
+5,000
| +313% | +$758 | ﹤0.01% | 5173 |
|
|
2018
Q4 | $1K | Hold |
1,597
| – | – | ﹤0.01% | 5161 |
|
|
2018
Q3 | $2K | Buy |
1,597
+650
| +69% | +$814 | ﹤0.01% | 4937 |
|
|
2018
Q2 | $2K | Hold |
947
| – | – | ﹤0.01% | 4926 |
|
|
2018
Q1 | $2K | Hold |
947
| – | – | ﹤0.01% | 4926 |
|
|
2017
Q4 | $2K | Hold |
947
| – | – | ﹤0.01% | 4837 |
|
|
2017
Q3 | $2K | Buy |
947
+500
| +112% | +$1.06K | ﹤0.01% | 4728 |
|
|
2017
Q2 | $1K | Hold |
447
| – | – | ﹤0.01% | 4819 |
|
|
2017
Q1 | $1K | Hold |
447
| – | – | ﹤0.01% | 4789 |
|
|
2016
Q4 | $2K | Hold |
447
| – | – | ﹤0.01% | 4583 |
|
|
2016
Q3 | $2K | Hold |
447
| – | – | ﹤0.01% | 4544 |
|
|
2016
Q2 | $2K | Hold |
447
| – | – | ﹤0.01% | 4471 |
|
|
2016
Q1 | $2K | Hold |
447
| – | – | ﹤0.01% | 4434 |
|
|
2015
Q4 | $3K | Hold |
447
| – | – | ﹤0.01% | 4283 |
|
|
2015
Q3 | $3K | Sell |
447
-1,000
| -69% | -$6.71K | ﹤0.01% | 4183 |
|
|
2015
Q2 | $9K | Hold |
1,447
| – | – | ﹤0.01% | 3782 |
|
|
2015
Q1 | $12K | Sell |
1,447
-5,150
| -78% | -$42.7K | ﹤0.01% | 3535 |
|
|
2014
Q4 | $33K | Buy |
+6,597
| New | +$33K | ﹤0.01% | 2647 |
|